CoronaVac es una vacuna contra la COVID-19 desarrollada por la...
wikipedia - 06 Aug 2021CoronaVac es una vacuna contra la COVID-19 desarrollada por la compañía farmacéutica Sinovac Biotech.
CoronaVac
CoronaVac es una vacuna contra la COVID-19 desarrollada por la compañía farmacéutica Sinovac Biotech.
A real-world study on the effectiveness of BBIBP-CorV and CoronaVac in Nanjing area | Scientific Reports
Nature.com - 06 Dec 2023A real-world study on the effectiveness of BBIBP-CorV and CoronaVac in Nanjing area | Scientific Reports ...
Association between BNT162b2 and CoronaVac vaccination and risk of CVD and mortality after COVID-19 infection: A ...
ScienceDirect.com - 17 Oct 2023Association between BNT162b2 and CoronaVac vaccination and risk of CVD and mortality after COVID-19 infection: A ... ...
The Sinovac-CoronaVac COVID-19 vaccine: What you need to know
World Health Organization (WHO) - 10 Jun 2022The Sinovac-CoronaVac COVID-19 vaccine: What you need to know ...
Thrombocytopenia and venous thromboembolic events after BNT162b2, CoronaVac, ChAdOx1 vaccines and SARS ...
Nature.com - 22 Nov 2023Thrombocytopenia and venous thromboembolic events after BNT162b2, CoronaVac, ChAdOx1 vaccines and SARS ... ...
(PDF) Immunogenicity and safety of inactivated SARS-CoV-2 vaccine (CoronaVac) using two-dose primary protocol in ...
ResearchGate - 26 Mar 2024(PDF) Immunogenicity and safety of inactivated SARS-CoV-2 vaccine (CoronaVac) using two-dose primary protocol in ... ...
How the Sinovac Covid-19 Vaccine Works
The New York Times - 24 Dec 2020How the Sinovac Covid-19 Vaccine Works ...
Covid: What do we know about China's coronavirus vaccines?
BBC.com - 13 Jan 2021Covid: What do we know about China's coronavirus vaccines? ...
Sinovac CoronaVac COVID-19 vaccine - Interim Recommendations and more information
Pan American Health Organization - 02 Jun 2021Sinovac CoronaVac COVID-19 vaccine - Interim Recommendations and more information ...
Interim recommendations for use of the inactivated COVID-19 vaccine, CoronaVac, developed by Sinovac
World Health Organization (WHO) - 02 Jun 2021Interim recommendations for use of the inactivated COVID-19 vaccine, CoronaVac, developed by Sinovac ...
Reduced ability to neutralize the Omicron variant among adults after infection and complete vaccination with ...
Nature.com - 08 May 2023Reduced ability to neutralize the Omicron variant among adults after infection and complete vaccination with ... ...
WHO validates Sinovac COVID-19 vaccine for emergency use and issues interim policy recommendations
World Health Organization (WHO) - 01 Jun 2021WHO validates Sinovac COVID-19 vaccine for emergency use and issues interim policy recommendations ...
Heterologous AD5-nCOV plus CoronaVac versus homologous CoronaVac vaccination: a randomized phase 4 trial
Nature.com - 27 Jan 2022Heterologous AD5-nCOV plus CoronaVac versus homologous CoronaVac vaccination: a randomized phase 4 trial ...
Background document on the inactivated vaccine Sinovac-CoronaVac against COVID-19
World Health Organization (WHO) - 02 Jun 2021Background document on the inactivated vaccine Sinovac-CoronaVac against COVID-19 ...
Immunogenicity and reactogenicity of SARS-CoV-2 vaccines BNT162b2 and CoronaVac in healthy adolescents
Nature.com - 28 Jun 2022Immunogenicity and reactogenicity of SARS-CoV-2 vaccines BNT162b2 and CoronaVac in healthy adolescents ...
Annexes to the recommendations for use of the Sinovac-CoronaVac vaccine against COVID-19: Grading of evidence ...
World Health Organization (WHO) - 02 Jun 2021Annexes to the recommendations for use of the Sinovac-CoronaVac vaccine against COVID-19: Grading of evidence ... ...
Vaccine effectiveness of CoronaVac against COVID-19 among children in Brazil during the Omicron period
Nature.com - 13 Aug 2022Vaccine effectiveness of CoronaVac against COVID-19 among children in Brazil during the Omicron period ...
Effectiveness of BNT162b2 and CoronaVac in children and adolescents against SARS-CoV-2 infection during Omicron ...
Nature.com - 05 Jan 2023Effectiveness of BNT162b2 and CoronaVac in children and adolescents against SARS-CoV-2 infection during Omicron ... ...
Booster dose of BNT162b2 after two doses of CoronaVac improves neutralization of SARS-CoV-2 Omicron variant ...
Nature.com - 29 Jun 2022Booster dose of BNT162b2 after two doses of CoronaVac improves neutralization of SARS-CoV-2 Omicron variant ... ...
Retrospective study of the immunogenicity and safety of the CoronaVac SARS-CoV-2 vaccine in people with ...
Nature.com - 25 Nov 2022Retrospective study of the immunogenicity and safety of the CoronaVac SARS-CoV-2 vaccine in people with ... ...